You have 9 free searches left this month | for more free features.

Condition

Multiple Myeloma (1)

Newly Diagnosed Multiple Myeloma (1)

Overall Status

Active, not recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 1 (1)

phase 3 (1)

Sponsor

Memorial Sloan Kettering Cancer Center (1)

PETHEMA Foundation (1)

Collaborator

Juno Therapeutics, Inc. (1)

Intervention

lenalidomide. (2)

bortezomib (1)

carfilzomib (1)

cyclophosphamide (1)

daratumumab (1)

dexamethasone (1)

egfrt/bcma-41bbz car t cell (1)

melphalan (1)

prednisone (1)

Study Documents

Intervention Type

drug (2)

biological (1)

Funder Type

Other (2)

Study Type

Interventional (2)

lenalidomide.

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Multiple Myeloma Trial in New York (EGFRt/BCMA-41BBz CAR T cell, Cyclophosphamide, Lenalidomide.)

Active, not recruiting

Multiple Myeloma

EGFRt/BCMA-41BBz CAR T cell
+2 more

New York, New York

Memorial Sloan Kettering Cancer Center

Mar 7, 2022

Newly Diagnosed Multiple Myeloma Trial in Spain (Lenalidomide., Carfilzomib, Bortezomib)

Recruiting

Newly Diagnosed Multiple Myeloma

Lenalidomide.
+6 more

A Coruña, Spain
+64 more

Mar 12, 2021